About.com Health

Share this article:
Company Profile
Silver Medal Winner for “Health Website of the Year” at the 2007 MM&M Awards, About.com Health is among the top health Web sites with more than 8 million visitors each month. About.com Health has the highest composition of women 25-54 and is the leader in many categories, like Arthritis, Pediatrics and Diet & Nutrition. (Source:Nielsen//NetRatings July 2007/@plan Summer 2007)

About.com is one the 15 most visited sites in the U.S. Each month, over 36 million unique visitors in the U.S. and 50 million worldwide trust About.com and its expert "Guides" to help them make more informed decisions on topics ranging from health, food, parenting and technology. Content on About.com is written by over 600 expert "Guides" who share their passions, expertise and how-to information in almost two million pieces of original content. This passion translates into reach. No other content site reaches more moms than About.com. We also reach more teens than MTV, more women than iVillage andmore men than ESPN. (Source: Nielsen//NetRatings July 2007)

Services and Offerings
Interactive opportunities include targeted media in over 600 categories, sponsorships, custom sites, promotions, mobile and podcasting.

If there is a way to reach a targeted consumer, About.com helps advertisers deliver those messages regardless of platform. Plus, our bedside manner is more like a visit from the family doctor, rather than a medical encyclopedia.
Share this article:
close

Next Article in News

Email Newsletters

More in News

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?

In sunny world of LASIK marketers, a dark underbelly

In sunny world of LASIK marketers, a dark ...

Last week, the former FDA branch chief who originally approved LASIK machines asked FDA to reconsider its denial last month of his petition to ban these devices.

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.